MAVEN INCOME AND GROWTH VCT PLC Maven Income and Growth VCT PLC Stock
Equities
MIG1
GB0004122858
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38 GBX | 0.00% |
|
0.00% | 0.00% |
| Jan. 16 | Alpha Core Strategies Fund announces an Equity Buyback. | CI |
| Jan. 16 | Alpha Core Strategies Fund authorizes a Buyback Plan. | CI |
| Sales 2022 | 4.59M 5.68M | Sales 2023 | 3.13M 3.87M | Capitalization | 54.94M 68.04M |
|---|---|---|---|---|---|
| Net income 2022 | 2M 2.48M | Net income 2023 | 1M 1.24M | EV / Sales 2022 | 8.19 x |
| Net cash position 2022 | 23.34M 28.9M | Net cash position 2023 | 9.83M 12.18M | EV / Sales 2023 | 14.4 x |
| P/E ratio 2022 |
20.3
x | P/E ratio 2023 |
40.4
x | Employees | - |
| Yield 2022 |
5% | Yield 2023 |
5.49% | Free-Float | 99.61% |
More Fundamentals
* Assessed data
More news
| 6 months | -2.56% |
1 week
37.00
38.00
1 month
37.0039.00
Current year
37.0039.00
1 year
36.2042.00
3 years
36.2047.00
5 years
36.2047.00
10 years
36.2075.00
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 64 | 07-02-28 | |
| Director/Board Member | 61 | 00-01-18 | |
Alison Fielding
BRD | Director/Board Member | 59 | 18-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 38 | 0.00% | 0 |
| 24-04-18 | 38 | 0.00% | 1,052 |
| 24-04-17 | 38 | 0.00% | 0 |
| 24-04-16 | 38 | 0.00% | 0 |
| 24-04-15 | 38 | 0.00% | 6,202 |
Delayed Quote London S.E., April 19, 2024 at 11:35 am EDT
More quotes
Maven Income and Growth VCT PLC is a United Kingdom-based generalist venture capital trust (VCT). The investment objective of the Company is to generate long-term investment returns with tax-free capital gains and regular tax-free dividend income for its shareholders. The Company seeks to invest in a diversified portfolio of smaller United Kingdom growth companies, either unquoted or traded on the Alternative Investment Market (AIM). It invests in various sectors, such as software; business services; pharmaceuticals, biotechnology and healthcare; data analytics; marketing and advertising technology; and pharmaceuticals, biotechnology and healthcare, among others. Maven Capital Partners UK LLP serves as manager for the Company.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 76.88M | |
| +31.41% | 12.02B | |
| +10.41% | 2.93B | |
| +2.96% | 1.4B | |
| -8.46% | 1.22B | |
| +43.91% | 624M | |
| -0.84% | 597M | |
| -19.31% | 518M | |
| +33.70% | 493M | |
| -4.17% | 492M |
- Stock Market
- Equities
- MIG1 Stock
